An evaluation of adalimumab on the risk of hospitalization in patients with Crohnʼs disease, data from CHARM

Autor: B Feagan, R Panaccione, W Sandborn, G DʼHaens, S Schreiber, P Rutgeerts, E Loftus, K Lomax, E Wu, P Mulani

Publikováno v: Inflammatory Bowel Diseases. 14:S2-S3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e5c0e4ef95cda0878d0325530cf1bda
https://doi.org/10.1097/00054725-200802001-00007

Adalimumab Therapy maintains remission for up to 3 Years in patients with moderately to severely active Crohnʼs Disease: Results From an Open-Label Extension of CHARM

Autor: P Pollack, J Colombel, K Lomax, William J. Sandborn, Remo Panaccione, G DʼHaens, Ji Li, P Rutgeerts

Publikováno v: Inflammatory Bowel Diseases. 15:S43

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d1f1f3f852a1edf52b2a3f765a7e1541
https://doi.org/10.1097/00054725-200912002-00129

Efficacy and Safety of Certolizumab Pegol in patients with active Crohnʼs Disease who previously lost response or were intolerant to Infliximab

Autor: S Vermeire, M Abreu, G DʼHaens, J Colombel, K Mitchev, R Fedorak, M Spehlmann, S Lee, W Sandborn, P Rutgeerts

Publikováno v: Inflammatory Bowel Diseases. 14:S30

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ff5369328d71b45e17699f9f6ad1aa0d
https://doi.org/10.1097/00054725-200812001-00101

SONIC

Autor: W Sandborn, P Rutgeerts, W Reinisch, G Mantzaris, A Kornbluth, D Rachmilewitz, S Lichtiger, G DʼHaens, C van der Woude, R Diamond, D Broussard, R Hegedus, J Colombel

Publikováno v: Inflammatory Bowel Diseases. 14:S1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31fad5f16313ea285ca0430341d1da8b
https://doi.org/10.1097/00054725-200812001-00001

Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.

Autor: Volkers A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Straatmijer T; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Duijvestein M; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands., Sales A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Levran A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Schaik F; University Medical Centre Utrecht, Utrecht, The Netherlands., Maljaars J; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Gecse K; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Ponsioen C; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Grootjans J; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Hanzel J; Department of Gastroenterology, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Tack G; Medical centre Leeuwarden, Leeuwarden, The Netherlands., Jansen J; OLVG, Amsterdam, The Netherlands., Hoentjen F; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada., de Boer N; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van der Marel S; Haaglanden Medical Centre, The Hague, The Netherlands., Dijkstra G; University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Oldenburg B; University Medical Centre Utrecht, Utrecht, The Netherlands., Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Meulen A; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., D Haens G; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Sep; Vol. 56 (6), pp. 1044-1054. Date of Electronic Publication: 2022 Jul 23.